Delivery Order SPE2DB22D3016-SPE2DB25FAVF4
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,357.39 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a commonly used antiemetic medication in military and federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $27,576.18. The award was made on May 30, 2025, with an ultimate completion date of June 2, 2025. This delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global...
- The Defense Logistics Agency awarded a $2,232.04 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, non-set-aside contract calls for performance at the vendor's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in military and federal healthcare settings to manage nausea and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count packages) with a ceiling value of $13,483.05. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a non-set-aside, competitively awarded contract. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed...
- The Defense Logistics Agency awarded a delivery order valued at $1,639.08 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery order has a completion date of September 2, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. Ondansetron is an anti-nausea medication commonly used in military and federal healthcare settings to...
- The Defense Logistics Agency awarded a $3,967.15 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packaging) with an ultimate completion date of August 19, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,576.33 for Ondansetron ODT 4 mg tablets (30-count packages) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in military and federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,413.35 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (30-count) on July 18, 2025, with an ultimate completion date of July 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs this work at its corporate office location. The...
- The Defense Logistics Agency awarded a delivery order valued at $4,279.41 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages). This firm fixed-price, non-set-aside contract was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ondansetron is a pharmaceutical used primarily for nausea and vomiting management in medical settings. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,573.56 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 22, 2025. The award was processed on August 21, 2025, with performance to occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under the...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FAVF4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,401.79 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is scheduled for completion by May 1, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in military and federal healthcare settings to manage nausea and vomiting. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion blanket purchasing agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen serves as a critical pharmaceutical vendor for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's extensive federal contracting history demonstrates its capacity to fulfill diverse medical procurement requirements through competitive procurement channels, with this transaction exemplifying the routine pharmaceutical supply deliveries that support operational readiness across the Department of Defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 4/30/25 |